These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37734596)

  • 1. Overnight 1-mg Dexamethasone Suppression Test for Screening Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS): What Happens when Serum Dexamethasone Is Below Cutoff? How Frequent Is it?
    Farinelli DG; Oliveira KC; Hayashi LF; Kater CE
    Endocr Pract; 2023 Dec; 29(12):986-993. PubMed ID: 37734596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Dose and Standard Overnight and Low Dose-Two Day Dexamethasone Suppression Tests in Patients with Mild and/or Episodic Hypercortisolism.
    Mojtahedzadeh M; Shaesteh N; Haykani M; Tran JLA; Mangubat M; Shahinian HK; Nachnani R; Zopey M; Saidian J; Thomas A; Lee ML; McCutcheon IE; Friedman TC
    Horm Metab Res; 2018 Jun; 50(6):453-461. PubMed ID: 29719879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test.
    Ueland GÅ; Methlie P; Kellmann R; Bjørgaas M; Åsvold BO; Thorstensen K; Kelp O; Thordarson HB; Mellgren G; Løvås K; Husebye ES
    Eur J Endocrinol; 2017 Jun; 176(6):705-713. PubMed ID: 28298353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method-Specific Cortisol and Dexamethasone Thresholds Increase Clinical Specificity of the Dexamethasone Suppression Test for Cushing Syndrome.
    Vogg N; Kurlbaum M; Deutschbein T; Gräsl B; Fassnacht M; Kroiss M
    Clin Chem; 2021 Jul; 67(7):998-1007. PubMed ID: 33997885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpretation of Abnormal Dexamethasone Suppression Test is Enhanced With Use of Synchronous Free Cortisol Assessment.
    Genere N; Kaur RJ; Athimulam S; Thomas MA; Nippoldt T; Van Norman M; Singh R; Grebe S; Bancos I
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e1221-e1230. PubMed ID: 34648626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
    al-Saadi N; Diederich S; Oelkers W
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of Laboratory Tests for the Diagnosis of Cushing Syndrome.
    Galm BP; Qiao N; Klibanski A; Biller BMK; Tritos NA
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32133504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yield of Serum Dexamethasone Measurement for Reducing False-Positive Results of Low-Dose Dexamethasone Suppression Testing.
    Roper SM
    J Appl Lab Med; 2021 Mar; 6(2):480-485. PubMed ID: 33484119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Out-patient screening for Cushing's syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests.
    Castro M; Elias PC; Quidute AR; Halah FP; Moreira AC
    J Clin Endocrinol Metab; 1999 Mar; 84(3):878-82. PubMed ID: 10084565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troglitazone induces CYP3A4 activity leading to falsely abnormal dexamethasone suppression test.
    Dimaraki EV; Jaffe CA
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3113-6. PubMed ID: 12843151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-day low-dose dexamethasone suppression test more accurate than overnight 1-mg in women taking oral contraceptives.
    Carton T; Mathieu E; Wolff F; Bouziotis J; Corvilain B; Driessens N
    Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00255. PubMed ID: 34277979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the 1 mg dexamethasone suppression test in patients with severe obesity.
    Lammert A; Nittka S; Otto M; Schneider-Lindner V; Kemmer A; Krämer BK; Birck R; Hammes HP; Benck U
    Obesity (Silver Spring); 2016 Apr; 24(4):850-5. PubMed ID: 26948683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New diagnostic criteria of adrenal subclinical Cushing's syndrome: opinion from the Japan Endocrine Society.
    Yanase T; Oki Y; Katabami T; Otsuki M; Kageyama K; Tanaka T; Kawate H; Tanabe M; Doi M; Akehi Y; Ichijo T
    Endocr J; 2018 Apr; 65(4):383-393. PubMed ID: 29576599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
    Reimondo G; Allasino B; Bovio S; Saba L; Ardito A; Angeli A; Terzolo M
    J Endocrinol Invest; 2011 Jan; 34(1):e1-5. PubMed ID: 20634637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early assessment of postoperative adrenal function is necessary after adrenalectomy for mild autonomous cortisol secretion.
    Foster T; Bancos I; McKenzie T; Dy B; Thompson G; Lyden M
    Surgery; 2021 Jan; 169(1):150-154. PubMed ID: 32693952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation.
    Ceccato F; Artusi C; Barbot M; Lizzul L; Pinelli S; Costantini G; Niero S; Antonelli G; Plebani M; Scaroni C
    J Endocrinol Invest; 2020 Aug; 43(8):1105-1113. PubMed ID: 32060745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
    Vieira-Correa M; Giorgi RB; Oliveira KC; Hayashi LF; Costa-Barbosa FA; Kater CE
    J Endocrinol Invest; 2019 Dec; 42(12):1435-1442. PubMed ID: 31456173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe obesity confounds the interpretation of low-dose dexamethasone test combined with the administration of ovine corticotrophin-releasing hormone in childhood Cushing syndrome.
    Batista DL; Courcoutsakis N; Riar J; Keil MF; Stratakis CA
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4323-30. PubMed ID: 18728165
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.